LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
47 hedge funds and large institutions have $219M invested in Landos Biopharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
47
Holders Change
+46
Holders Change %
+4,600%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$141M |
| 2 |
RI
2
RTW Investments
New York
|
$38.3M |
| 3 |
LGM
3
Logos Global Management
San Francisco,
California
|
$7.07M |
| 4 |
O
4
OrbiMed
New York
|
$6.56M |
| 5 |
DM
5
Deerfield Management
New York
|
$4.33M |
Top Sellers
No sellers this quarter
